Renewed hope for treatment of pain and depression
Researchers at the Department of Infection and Immunity of the Luxembourg Institute of Health (LIH) have developed LIH383, a novel molecule that binds to and blocks a previously unknown opioid receptor in the brain, thereby ...
Jun 19, 2020
0
80